Hypertrichosis of the eyelashes caused by bimatoprost.

Antonella Tosti, Massimiliano Pazzaglia, Stylianos Voudouris, Giovanni Tosti

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

The phenyl-substituted analog of prostaglandin F 2alpha , latanoprost (Xalatan; Pfizer, Inc, New York, NY) is an intraocular pressure (IOP)-lowering drug for use in patients with glaucoma and ocular hypertension. Latanoprost has been shown to stimulate eyelash hypertrichosis and has recently been proposed as a possible treatment for alopecia areata involving the eyelashes. We report a case of hypertrichosis of the eyelashes caused by the prostamide bimatoprost (Lumigan; Allergan, Inc, Irvine, Calif), a new IOP-lowering drug.

Original languageEnglish
JournalJournal of the American Academy of Dermatology
Volume51
Issue number5 Suppl
StatePublished - Nov 1 2004
Externally publishedYes

Fingerprint

latanoprost
Eyelashes
Hypertrichosis
Intraocular Pressure
Synthetic Prostaglandins F
Alopecia Areata
Ocular Hypertension
Pharmaceutical Preparations
Glaucoma
Bimatoprost

ASJC Scopus subject areas

  • Dermatology

Cite this

Hypertrichosis of the eyelashes caused by bimatoprost. / Tosti, Antonella; Pazzaglia, Massimiliano; Voudouris, Stylianos; Tosti, Giovanni.

In: Journal of the American Academy of Dermatology, Vol. 51, No. 5 Suppl, 01.11.2004.

Research output: Contribution to journalArticle

Tosti, A, Pazzaglia, M, Voudouris, S & Tosti, G 2004, 'Hypertrichosis of the eyelashes caused by bimatoprost.', Journal of the American Academy of Dermatology, vol. 51, no. 5 Suppl.
Tosti, Antonella ; Pazzaglia, Massimiliano ; Voudouris, Stylianos ; Tosti, Giovanni. / Hypertrichosis of the eyelashes caused by bimatoprost. In: Journal of the American Academy of Dermatology. 2004 ; Vol. 51, No. 5 Suppl.
@article{7a4170348bd5461a8e6e6425c0919b53,
title = "Hypertrichosis of the eyelashes caused by bimatoprost.",
abstract = "The phenyl-substituted analog of prostaglandin F 2alpha , latanoprost (Xalatan; Pfizer, Inc, New York, NY) is an intraocular pressure (IOP)-lowering drug for use in patients with glaucoma and ocular hypertension. Latanoprost has been shown to stimulate eyelash hypertrichosis and has recently been proposed as a possible treatment for alopecia areata involving the eyelashes. We report a case of hypertrichosis of the eyelashes caused by the prostamide bimatoprost (Lumigan; Allergan, Inc, Irvine, Calif), a new IOP-lowering drug.",
author = "Antonella Tosti and Massimiliano Pazzaglia and Stylianos Voudouris and Giovanni Tosti",
year = "2004",
month = "11",
day = "1",
language = "English",
volume = "51",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "5 Suppl",

}

TY - JOUR

T1 - Hypertrichosis of the eyelashes caused by bimatoprost.

AU - Tosti, Antonella

AU - Pazzaglia, Massimiliano

AU - Voudouris, Stylianos

AU - Tosti, Giovanni

PY - 2004/11/1

Y1 - 2004/11/1

N2 - The phenyl-substituted analog of prostaglandin F 2alpha , latanoprost (Xalatan; Pfizer, Inc, New York, NY) is an intraocular pressure (IOP)-lowering drug for use in patients with glaucoma and ocular hypertension. Latanoprost has been shown to stimulate eyelash hypertrichosis and has recently been proposed as a possible treatment for alopecia areata involving the eyelashes. We report a case of hypertrichosis of the eyelashes caused by the prostamide bimatoprost (Lumigan; Allergan, Inc, Irvine, Calif), a new IOP-lowering drug.

AB - The phenyl-substituted analog of prostaglandin F 2alpha , latanoprost (Xalatan; Pfizer, Inc, New York, NY) is an intraocular pressure (IOP)-lowering drug for use in patients with glaucoma and ocular hypertension. Latanoprost has been shown to stimulate eyelash hypertrichosis and has recently been proposed as a possible treatment for alopecia areata involving the eyelashes. We report a case of hypertrichosis of the eyelashes caused by the prostamide bimatoprost (Lumigan; Allergan, Inc, Irvine, Calif), a new IOP-lowering drug.

UR - http://www.scopus.com/inward/record.url?scp=16644384472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16644384472&partnerID=8YFLogxK

M3 - Article

C2 - 15577756

AN - SCOPUS:16644384472

VL - 51

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 5 Suppl

ER -